RESTRICTED STOCK (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
Stock Options And Restricted Stock
Non-cash compensation expense	$ 349,000	$ 355,000
Aggregate restricted shares of Common Stock pursuant to 2008 plan			36,936
Grant date fair value of restricted stock grants			111,000
Shares of non-vested restricted stock			125,035
Total unrecognized compensation expense	$ 296,000		$ 296,000
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval			51,685
Yearly [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval			73,350